top of page

​China Reimbursement Analysis for the German Healthcare Export Initiative

Context

Through its healthcare export initiative, the German Federal Ministry for Economic Affairs and Energy supports the German healthcare industry in entering foreign markets. Germany Trade & Invest (GTAI), the federal economic development agency, implements the initiative on the ministry’s behalf. German small and medium-sized healthcare companies that are active in China, or plan to be, need a reliable picture of how its health insurance and reimbursement system works.

​

Why this matters for market entry: reimbursement largely decides whether a product reaches patients in China at a viable price. SILREAL applies the same analysis in its market-entry assessments, which test regulatory clearance, reimbursement, procurement and partner risk before capital is committed.

The work

Chenchao Liu, Managing Director of SILREAL, has worked for the export initiative on several occasions.

  • Health system: Prepared and presented information on China’s healthcare system, with the health insurance system and reimbursement at the centre.

  • Trends: Analysed current developments in the Chinese healthcare market.

  • Recommendations: Developed recommendations for action for German small and medium-sized healthcare companies.

Doctor with a tablet
Hospital bed

What the certificate records

  • Scope: Substantial contribution to preparing and presenting information on China’s healthcare system for the export initiative.

  • Expertise: Extensive and well-founded knowledge of both the healthcare industry and the Chinese market.

  • Working style: A very high degree of reliability, structure and efficiency.

  • Signatory: Axel Lohse, Deputy Director, Healthcare Export Initiative, Germany Trade & Invest.

bottom of page